[Federal Register Volume 67, Number 15 (Wednesday, January 23, 2002)]
[Notices]
[Page 3168]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-1642]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Availability for Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. Patent Concerning DNA Vaccines Against Tick-Borne 
Flaviviruses

AGENCY: U.S. Army Medical Research and Materiel Command, DOD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 37 CFR 404.6, announcement is made of the 
availability for licensing of U.S. Patent No. 6,258,788 entitled ``DNA 
Vaccines Against Tick-Borne Flaviviruses'' issued 07/10/01. Foreign 
rights also available (PCT/US98/25322). This patent has been assigned 
to the United States Government as represented by the Secretary of the 
Army.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, Maryland 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research & Technology Assessment, (301) 619-6664. Both 
at telefax (301 619-5034.

SUPPLEMENTARY INFORMATION: Particle mediated immunization of tick-borne 
flavivirus genes confers homologous and heterologous protection against 
tick borne encephalitis.

Luz D. Ortiz,
Army Federal Register Liaison Officer.
[FR Doc. 02-1642 Filed 1-22-02; 8:45 am]
BILLING CODE 3710-08-M